Corrigendum to “Bone marrow mesenchymal stem cells alleviate the daunorubicin-induced subacute myocardial injury in rats through inhibiting infiltration of T lymphocytes and antigen-presenting cells” [Biomed. Pharmacother. 121 (2020) 109157]

Corrigendum to “Bone marrow mesenchymal stem cells alleviate the daunorubicin-induced subacute myocardial injury in rats through inhibiting infiltration of T lymphocytes and antigen-presenting cells” [Biomed. Pharmacother. 121 (2020) 109157]

Bibliographic Details
Main Authors:	Qiuru Chen, Yuxin Zhang, Haojie Zhu, Xiaohong Yuan, Xiaofeng Luo, Xueqiong Wu, Shaozhen Chen, Yongquan Chen, Jingjing Xu, Hajji Ally Issa, Zhihong Zheng, Jianda Hu, Ting Yang
Format:	Article
Language:	English
Published:	Elsevier 2023-08-01
Series:	Biomedicine & Pharmacotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S0753332223007308

Similar Items

Retraction notice to “Effect of an aqueous extract of Averrhoa carambola L. on endothelial function in rats with ventricular remodelling” [Biomed. Pharmacother. 121 (2019) 109612]
by: Xingmei Liang, et al.
Published: (2024-04-01)

Retraction notice to “LNCRNA CDKN2B-AS1 regulates mesangial cell proliferation and extracellular matrix accumulation via miR-424-5p/HMGA2 axis” [Biomed. Pharmacother. 121 (2020) 109622]
by: Yang Li, et al.
Published: (2023-08-01)

Corrigendum to “Valproate, divalproex, valpromide: Are the differences in indications justified?” [Biomed. Pharmacother., 158 (2023) 114051]
by: Clément Delage, et al.
Published: (2023-12-01)

Corrigendum to “Effects of oligonol on the submandibular gland in ovariectomized rats” [Biomed. Pharmacother. 141 (2021) 111897]
by: Jeong Hun Kim, et al.
Published: (2023-09-01)

Corrigendum to “Tegaserod maleate exhibits antileukemic activity by targeting TRPM8” [Biomed. Pharmacother. 154 (2022) 113566]
by: Xiaoling Xie, et al.
Published: (2023-10-01)

Retraction Notice to “Pharmacological evaluation of continentalic acid for antidiabetic potential” [Biomed. Pharmacother. 138 (2021) 111411]
by: Iqra Liaquat, et al.
Published: (2024-01-01)

Corrigendum to “Steatosis in metabolic diseases: A focus on lipolysis and lipophagy” [Biomed. Pharmacother. 160 (2023) 114311]
by: Xingtao Zhao, et al.
Published: (2023-07-01)

Corrigendum to “Insights into the implementation of Fibronectin 1 in the cartilage tissue engineering” [Biomed. Pharmacother. 148 (2022) 112782]
by: Murad Alahdal, et al.
Published: (2022-09-01)

Corrigendum to “The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy” Biomed. Pharmacother. 165 (2023) 114893
by: Shuo Yuan, et al.
Published: (2024-02-01)

Retraction notice to “Corrigendum to 'mPEG-b-P(Glu-co-Phe) nanoparticles increase gastric retention time and gastric ulcer treatment efficacy of 20(S)-ginsenoside Rg3' [Biomed. Pharmacother. 146 (2022) 112608]” [Biomed. Pharmacother. 152 (2022) 113213]
by: Lanqing Cao, et al.
Published: (2023-04-01)

Corrigendum to: “Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of cell death” [Biomed. Pharmacother. 153 (2022) 113511]
by: Li Liu, et al.
Published: (2023-12-01)

Autophagy inhibition enhances daunorubicin-induced apoptosis in K562 cells.
by: Weidong Han, et al.
Published: (2011-01-01)

Corrigendum to “Neopetroside-B alleviates doxorubicin-induced cardiotoxicity via mitochondrial protection” [Biomed. Pharmacother. 165 (2023) 115232]
by: Chang Shin Yoon, et al.
Published: (2023-12-01)

Retraction notice to “Salidroside alleviates cigarette smoke-induced COPD in mice” [Biomed. Pharmacother. 86 (2017) 155–161]
by: Fen Luo, et al.
Published: (2023-04-01)

Corrigendum to “Ferroptosis: A new view on the prevention and treatment of diabetic kidney disease with traditional Chinese medicine” Biomed. Pharmacother. 170 (2024) 115952
by: Yu Chen, et al.
Published: (2024-01-01)

Retraction notice to “Alkannin protects human renal proximal tubular epithelial cells from LPS-induced inflammatory injury by regulation of microRNA-210” [Biomed. Pharmacother. 108 (2018) 1679–1685]
by: Yiheng Chen, et al.
Published: (2022-06-01)

Corrigendum to ‘Jinlong Capsule (JLC) inhibits proliferation and induces apoptosis in human gastric cancer cells in vivo and in vitro’ Biomed. Pharmacother. 107 (2018) 738–745
by: Dan Li, et al.
Published: (2023-10-01)

Corrigendum to “Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway” [Biomed. Pharmacother. 115 (2019) 108922]
by: Xiaohong Xu, et al.
Published: (2022-05-01)

Corrigendum to “Betaine prevents and reverses the behavioral deficits and synaptic dysfunction induced by repeated ketamine exposure in mice” by Shao-Tsu Chen [Biomed. Pharmacother. 144 (2021) 112369]
by: Shao-Tsu Chen, et al.
Published: (2023-07-01)

Corrigendum to “The potential molecular pathways of astragaloside-IV in colorectal cancer: A systematic review” [Biomed. Pharmacother. 167 (2023) 115625]
by: Tang Ziyang, et al.
Published: (2023-12-01)

Erratum to alkaloids in commercial preparations of California poppy – Quantification, intestinal permeability and microbiota interactions [Biomed. Pharmacother. 166 (2023) 115420]
by: Antoine Chauveau, et al.
Published: (2023-11-01)

Retraction notice to “miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer” [Biomed. Pharmacother. 95 (2017) 1718–1724]
by: Yuanqiang Lin, et al.
Published: (2024-02-01)

Retraction notice to “MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14” [Biomed. Pharmacother. 98 (2018) 636–642]
by: Qi Li, et al.
Published: (2024-04-01)

Retraction notice to “Icariin inhibits cell proliferation, migration and invasion by down-regulation of microRNA-625-3p in thyroid cancer cells” [Biomed. Pharmacother. 109 (2019) 2456–2463]
by: Lei Fang, et al.
Published: (2022-06-01)

Corrigendum to “Analysis of the anti-inflammatory potential of Brassica bioactive compounds in a human macrophage-like cell model derived from HL-60 cells” [Biomed. Pharmacother. 149 (2022) 112804]
by: Antonio José Ruiz-Alcaraz, et al.
Published: (2022-08-01)

Intrinsic and extrinsic apoptosis responses in leukaemia cells following daunorubicin treatment
by: Hussain Mubarak Al-Aamri, et al.
Published: (2021-04-01)

Corrigendum to “Emerging strategy for the treatment of urothelial carcinoma: Advances in antibody-drug conjugates combination therapy” Biomed. Pharmacother. 171 (2024) 116152
by: Xiangyun You, et al.
Published: (2024-04-01)

Retraction notice to 'Potential role of andrographolide in the proliferation of osteoblasts mediated by the ERK signaling pathway' [Biomed. Pharmacother. 83 (2016) 1335–1344]
by: Bo Li, et al.
Published: (2023-07-01)

Corrigendum to “Sacubitril/valsartan combination enhanced cardiac glycophagy and prevented the progression of murine diabetic cardiomyopathy” [Biomed. Pharmacother. 153 (2022) 113382]
by: Dina Salem Abdelaziz Elshenawy, et al.
Published: (2022-12-01)

Retraction notice to “MicroRNA-361-5p inhibits papillary thyroid carcinoma progression by targeting ROCK1” [Biomed. Pharmacother. 102 (2018) 988–995]
by: Rui Li, et al.
Published: (2023-08-01)

Retraction notice to “miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1” [Biomed. Pharmacother. 106 (2018) 1072–1081]
by: Huixing Deng, et al.
Published: (2023-06-01)

Retraction notice to “ATPase inhibitory factor 1 is a prognostic marker and contributes to proliferation and invasion of human gastric cancer cells” [Biomed. Pharmacother. 70 (2015) 90–96]
by: Tao Yin, et al.
Published: (2023-04-01)

‘Corrigendum to “Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal carcinoma cells” [Biomed. Pharmacother. 98 (2018) 36–44]’
by: Yuwan Zhao, et al.
Published: (2022-09-01)

Retraction notice to “TUG1 alleviates hypoxia injury by targeting miR-124 in H9c2 cells” [Biomed. Pharmacother. 103 (2018) 1669–1677]
by: Nianxin Jiang, et al.
Published: (2022-06-01)

Editor’s Note on “Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: An estimate” [Biomed. Pharmacother. 171 (2024) 116055]
by: Danyelle Townsend
Published: (2024-02-01)

Corrigendum to “Antidiabetic and antioxidant activities of Mitragyna speciosa (kratom) leaf extract in type 2 diabetic rats” [Biomed. Pharmacother. 162 (2023) 114689]
by: Pengpeng Zhang, et al.
Published: (2023-08-01)

Corrigendum to “vanillic acid attenuates effects of transient bilateral common carotid occlusion and reperfusion in rats” [Biomed. Pharmacother. 96 (2017) 667–674]
by: Seyed Esmaeil Khoshnam, et al.
Published: (2023-09-01)

Corrigendum to: “Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis”, [Biomed. Pharmacother., 161; (2023): 114472]
by: Liang Shan, et al.
Published: (2023-06-01)

Retraction notice to 'Neferine inhibits proliferation, migration and invasion of U251 glioma cells by down-regulation of miR-10b' [Biomed. Pharmacother. 109 (2019) 1032–1040]
by: Hua-Xin Liang, et al.
Published: (2021-12-01)

Retraction notice to 'Schizandrin A enhances chemosensitivity of colon carcinoma cells to 5-fluorouracil through up-regulation of miR-195' [Biomed Pharmacother 99 (2018) 176–183]
by: Dongfang Kong, et al.
Published: (2022-05-01)